News and Trends 8 Mar 2023 Could changing mRNA provide a new target for Alzheimer’s disease? …of peripheral immune cells into the brain, and may provide a new target for treatment of Alzheimer’s disease. A presumed trigger for the development of Alzheimer’s disease is the accumulation… March 8, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
2024 biotech funding tracker: recent highlights …solid tumors Asceneuron (Switzerland) : $100 million series C | tau-targeting therapies | phase 2 in Alzheimer’s HepaRegeniX (Germany) : €15 million ($16.4 million) series C | regenerative therapies |… February 23, 2024 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2020 Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s disease drug has increased in worth by €38M with a new milestone payment. AC Immune… March 24, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 3 Oct 2023 Five impactful biotech companies to know in New York …targeting diseases such as depression, Alzheimer’s disease agitation, migraine, narcolepsy, and fibromyalgia. In Just last year, the U.S. Food and Drug Administration (FDA) approved Axsome’s drug Auvelity (dextromethorphan HBr -bupropion… October 3, 2023 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 27 Jun 2025 Psychedelics sans side effects: neuroplastogens gain ground …of the protein ELK-1 in memory and its implication in neurodegenerative diseases like Alzheimer’s, which affects around 24 million people worldwide. Since then, the team has been busy trying to… June 27, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
More News! 10 Dec 2024 Biotech in 2024: A retrospective …reminded Del Bourgo. On several occasions, including this year, we wrote about how AI was contributing to and reshaping biotech in key areas such as cancer or Alzheimer’s. Time will… December 10, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Startup Scout 10 Nov 2022 ResQ Biotech is using bacteria to discover Alzheimer’s treatments Protein misfolding underlies many incurable conditions such as Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). The Greek startup ResQ Biotech is harnessing bacteria to test potential peptide treatments for these… November 10, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 21 Dec 2017 Scientists Find New Immune Target to Stop Progression of Alzheimer’s Scientists have described a new mechanism by which the immune system can drive Alzheimer’s and shown that blocking it can prevent the disease in mice. A study published yesterday in… December 21, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Jul 2025 10 biotech companies leading the way in Denmark …GSK for Alzheimer’s disease treatment Launched by Novo Holdings in 2021 with $73 million in series A funding, Muna Therapeutics is focused on the development of small molecule therapies for… July 29, 2025 - 16 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 30 Oct 2018 Shuttles, Bubbles and Ultrasound: Crossing the Blood–Brain Barrier …cancer and Alzheimer’s easier. The blood–brain barrier is the gatekeeper to the brain. This highly selective protective sheath regulates the flow of substances in and out and prevents toxins and… October 30, 2018 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Jan 2023 The biggest biotech trends that will shape 2023 …and investors see developing over 2023. Rollout and readout of Alzheimer’s drugs The accelerated approval of lecanemab, branded as Leqembi, heralded a promising development for the treatment of Alzheimer’s disease. … January 12, 2023 - 9 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 23 Dec 2016 The 8 Biggest Biotech Medical Fails of 2016 in Europe …in Alzheimer’s. Since learning from our errors is one of the keys to success, we’ve made a list of 8 big disappointments in European biotech this year with the hope… December 23, 2016 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email